Offer - Urjas Oil for just ₹ 1 X
Pramipex ER 0.375 Tablet is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of Parkinson's Disease. Pramipex ER 0.375 Tablet also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Pramipex ER 0.375 Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Pramipex ER 0.375 Tablet can also lead to other problems, which have been listed below. Usually, these side effects of Pramipex ER 0.375 Tablet go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Pramipex ER 0.375 Tablet has a Moderate effect for pregnant women and Severe effect on lactating mothers. Warnings related to Pramipex ER 0.375 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Schizophrenia, Heart Disease, Kidney Disease must refrain from the use of Pramipex ER 0.375 Tablet since this can cause severe adverse effects.
Besides this, Pramipex ER 0.375 Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Pramipex ER 0.375 Tablet is considered not safe while driving, and is not addictive.
Pramipex ER 0.375 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Pramipex ER 0.375 Tablet safe for pregnant women?
Pramipex can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Pramipex right away. Take your doctor's advice before taking it again.
Is the use of Pramipex ER 0.375 Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Pramipex. It should only be taken after medical advice.
What is the effect of Pramipex ER 0.375 Tablet on the Kidneys?
Pramipex rarely harms the kidneys.
What is the effect of Pramipex ER 0.375 Tablet on the Liver?
There are no any side effects of Pramipex on the liver.
What is the effect of Pramipex ER 0.375 Tablet on the Heart?
Pramipex has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Pramipex ER 0.375 Tablet unless your doctor advises you to do so -
Is this Pramipex ER 0.375 Tablet habit forming or addictive?
Forming a habit of Pramipex ER 0.375 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Pramipex ER 0.375 Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Pramipex ER 0.375 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Yes, this Pramipex ER 0.375 Tablet works for mental disorders.
Interaction between Food and Pramipex ER 0.375 Tablet
Taking Pramipex ER 0.375 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Pramipex ER 0.375 Tablet
Consult your doctor before consuming alcohol while taking Pramipex ER 0.375 Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Mirapex® (pramipexole dihydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1043-1044
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 430-431